EP
CVET

Eudaimonia Partners’s Covetrus, Inc. Common Stock CVET Stock Holding History

Eudaimonia Partners’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-81
Closed -$2K – 1486
2021
Q1 		$2K Buy
+81
New +$2.76K ﹤0.01% 1510

Other funds holding CVET

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Eudaimonia Partners's CVET Position: Q2 2021 in Review

Eudaimonia Partners sold out of Covetrus, Inc. Common Stock (CVET) in Q2 2021, closing a stake of 81 shares — an estimated $2K sold.

Eudaimonia Partners first reported a position in CVET in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 269 funds tracked by Wall St. Rank hold CVET as of Q2 2021.

  • Eudaimonia Partners reported no remaining Covetrus, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 81 Covetrus, Inc. Common Stock shares in Q2 2021, an estimated $2K.
  • Eudaimonia Partners first reported a position in Covetrus, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Covetrus, Inc. Common Stock position peaked at $2K in Q1 2021.
  • 269 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.